Description

Imatinib Mesylate 400mg is a targeted therapy used to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting specific tyrosine kinases, blocking cancer cell proliferation and improving overall survival rates in patients undergoing treatment.